Neurolief
PrivateLast Round
Convertible Debt
Mar 26, 2026
Total Funding Raised
$22.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurolief is a medical device company that develops non-invasive, wearable brain neuromodulation systems for the at-home treatment of neurological and neuropsychiatric disorders such as migraine and major depressive disorder.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurolief Comparables
Compare Neurolief with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sooma | 84% | |
| Flow Neuroscience | 83% | |
| Theranica | 82% | |
Neurolief Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 26, 2026 | ||||
| Convertible Debt | Aug 21, 2025 | ||||
| Strategic | Dec 28, 2023 | ||||
| Series A | May 9, 2018 | ||||
| Series A | Jun 1, 2017 | ||||
Seed | Jan 1, 2015 |
Neurolief Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Champel Capital | Series A |
| Terralab Ventures | Series A, Seed |
| KT Squared | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 24, 80% of headcount.
- Mar 26, 2026
Raised $6M in early funding.
Neurolief Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurolief's valuation, stock price, and market status.